Dare Bioscience DARE
NASDAQ DARE
$0.81 +0.00 (+0.12%)
As of: Aug 21, 2026 · 9:36 AM EDT

Dare Bioscience (DARE) Goodwill (2017)

Dare Bioscience's (DARE) quarterly Goodwill came in at $5.2 million in Q4 2017, down 59.73% on a QoQ basis from $12.9 million in Q3 2017.

Dare Bioscience (DARE) Goodwill (2017) Analysis & Trends

Dare Bioscience (DARE) has 1 years of Goodwill data on file, last reported at $5.2 million in Q4 2017.

  • Quarterly Goodwill changed N/A year-over-year to $5.2 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $5.2 million (changed N/A YoY) and the FY2017 annual result came in at $5.2 million, changed N/A from the prior year.
  • Goodwill fell to $5.2 million in Q4 2017, from $12.9 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $12.9 million in Q3 2017 to a low of $5.2 million in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.04 Bn 130.19 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.58 Bn 77.59 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.34 Bn 1.37 Bn
4 Moderna 56.52 Bn 51.38 Bn 52.00 Mn
5 BeOne Medicines 42.04 Bn 36.94 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.67 Bn 27.36 Bn 992.69 Mn
7 Insmed 27.27 Bn 26.11 Bn 358.27 Mn
8 BioNTech SE 27.14 Bn 8.75 Bn 668.28 Mn
9 Royalty Pharma 27.12 Bn 26.28 Bn -
10 Dare Bioscience 12.21 Mn -406,442.64 -132,343.00

Historic Data

Download Data
DateValue
Dec 31, 2017 5.19 Mn
Sep 30, 2017 12.88 Mn